2021
Health Care Utilization Before and After the “Muslim Ban” Executive Order Among People Born in Muslim-Majority Countries and Living in the US
Samuels EA, Orr L, White EB, Saadi A, Padela AI, Westerhaus M, Bhatt AD, Agrawal P, Wang D, Gonsalves G. Health Care Utilization Before and After the “Muslim Ban” Executive Order Among People Born in Muslim-Majority Countries and Living in the US. JAMA Network Open 2021, 4: e2118216. PMID: 34328502, PMCID: PMC8325073, DOI: 10.1001/jamanetworkopen.2021.18216.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAmbulatory Care FacilitiesAppointments and SchedulesEmergency Service, HospitalEmigrants and ImmigrantsEmigration and ImmigrationFemaleHumansIslamMaleMiddle AgedMinnesotaPatient Acceptance of Health CarePrimary Health CareRefugeesRetrospective StudiesUnited StatesYoung AdultConceptsPrimary care appointmentsHealth care utilizationED visitsCare appointmentsCohort studyCare utilizationEmergency departmentGroup 1Primary care clinic visitsAdditional ED visitsRetrospective cohort studyPrimary care visitsPrimary care clinicsCare visitsAdult patientsClinic visitsPrimary outcomeCare clinicsStudy groupMAIN OUTCOMEGroup 2Group 3Visit trendsPatientsVisits
2018
Adherence to the International Committee of Medical Journal Editors’ (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals
Gopal AD, Wallach JD, Aminawung JA, Gonsalves G, Dal-Ré R, Miller JE, Ross JS. Adherence to the International Committee of Medical Journal Editors’ (ICMJE) prospective registration policy and implications for outcome integrity: a cross-sectional analysis of trials published in high-impact specialty society journals. Trials 2018, 19: 448. PMID: 30134950, PMCID: PMC6106722, DOI: 10.1186/s13063-018-2825-y.Peer-Reviewed Original ResearchConceptsPrimary outcome dataOutcome dataCross-sectional analysisUnregistered trialsTrial characteristicsClinical trialsFavorable findingsProfessional medical societiesMedical societiesIndustry-funded trialsFrequency of registrationPrimary outcomeRegistered trialsEnrollment siteProspective fashionChi-square analysisProportion of trialsOriginal research reportsInitial ascertainmentTrialsHigh-impact journalsMedical Journal EditorsRegistration timingRetrospective registrationLower rates
2016
New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners
Beckman AL, Bilinski A, Boyko R, Camp GM, Wall AT, Lim JK, Wang EA, Bruce RD, Gonsalves GS. New Hepatitis C Drugs Are Very Costly And Unavailable To Many State Prisoners. Health Affairs 2016, 35: 1893-1901. PMID: 27702964, DOI: 10.1377/hlthaff.2016.0296.Peer-Reviewed Original ResearchConceptsHepatitis C epidemicHepatitis CC epidemicDrug discount programsLedipasvir/sofosbuvirTwelve-week courseNew hepatitis C drugsHealth care facilitiesHepatitis C drugsAntiviral medicationsCare facilitiesC drugsMedicationsSofosbuvirDiscount programPharmaceutical companiesEpidemicDepartmentDepartment of CorrectionsAntiviralsState prisonersState prisonsRelease